Angela Aggrey

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections

J. Motsch, Cláudia Murta de Oliveira, V.P. Stus et al. · Clinical Infectious Diseases · 2019 · 384 citations · Full text

Platelets Present Antigen in the Context of MHC Class I

Lesley M. Chapman, Angela Aggrey, David Field et al. · The Journal of Immunology · 2012 · 220 citations · Full text

Platelet Induction of the Acute-Phase Response Is Protective in Murine Experimental Cerebral Malaria

Angela Aggrey, Kalyan Srivastava, Sara Ture et al. · The Journal of Immunology · 2013 · 85 citations · Full text

Platelet Factor 4 Regulation of Monocyte KLF4 in Experimental Cerebral Malaria

Kalyan Srivastava, David Field, Angela Aggrey et al. · PLoS ONE · 2010 · 46 citations · Full text

Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections

Keith S. Kaye, Helen W. Boucher, Michelle Brown et al. · Antimicrobial Agents and Chemotherapy · 2020 · 33 citations · Full text